Valerio L, Guidoccio F, Giani C, Tardelli E, et al. [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival. J Clin Endocrinol Metab 2021 Apr 26. pii: 6253809. doi: 10.1210.
PMID: 33901285